BioMarin

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BioMarin and other ETFs, options, and stocks.

About BMRN

BioMarin Pharmaceutical, Inc. engages in the development and commercialization of therapies for people with serious and life-threatening rare diseases and medical conditions. Its pipeline products include Valoctocogene roxaparvovec, Vosoritide, and BMN 307.

CEO

Alexander Hardy

CEOAlexander Hardy

Employees

3,401

Employees3,401

Headquarters

San Rafael, California

HeadquartersSan Rafael, California

Founded

1997

Founded1997

Employees

3,401

Employees3,401

BMRN Key Statistics

Market cap

15.69B

Market cap15.69B

Price-Earnings ratio

76.84

Price-Earnings ratio76.84

Dividend yield

—

Dividend yield—

Average volume

2.27M

Average volume2.27M

High today

$83.02

High today$83.02

Low today

$81.81

Low today$81.81

Open price

$82.52

Open price$82.52

Volume

904.83K

Volume904.83K

52 Week high

$99.56

52 Week high$99.56

52 Week low

$76.02

52 Week low$76.02

BMRN News

Yahoo Finance 23h

Insider Sale: EVP, Chief Commercial Officer Jeffrey Ajer Sells 5,000 Shares of Biomarin ... - Yahoo Finance

On May 2, 2024, Jeffrey Ajer, the Executive Vice President and Chief Commercial Officer of Biomarin Pharmaceutical Inc (NASDAQ:BMRN), sold 5,000 shares of the c...

TipRanks 1d

BioMarin data supportive of potential label expansion, says Citi

Citi says new data from the Phase 2 study of vosoritide for the treatment of select genetic causes of short stature show encouraging annualized growth velocity...

TipRanks 2d

BioMarin announces new Voxzogo data in children with achondroplasia

BioMarin Pharmaceutical announces “positive” new data supporting the safety and efficacy of Voxzogo in children with achondroplasia, as well as positive data fo...

Analyst ratings

70%

of 30 ratings

Buy

70%

Hold

30%

Sell